Search results for Exenatide - Clinical Trials Registry - ICH GCP

Example: Heart Attack

Search clinical trials for: Exenatide

Total 249 results

NCT05610800

Not yet recruiting

Exenatide for Smoking Cessation and Prevention of Weight Gain

Conditions: Smoking Cessation, Weight Gain
NCT02586831

Not yet recruiting

Diabetes Islet Preservation Immune Treatment

Conditions: Diabetes Mellitus, Type 1, Hypoglycemia, Autoimmune Diseases, Diabetes Mellitus
NCT03029351

Terminated

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Conditions: Type2 Diabetes, Kidney Diseases
NCT03961256

Completed

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Conditions: Pre Diabetes
NCT04520490

Recruiting

Brain Activation and Satiety in Children 2

Conditions: Childhood Obesity
NCT02673931

Active, not recruiting

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

Conditions: Coronary Disease, Shock, Cardiogenic, Renal Failure, Stroke, Brain Injury, Aortic Valve Disease
NCT05073692

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Conditions: Type 2 Diabetes Mellitus, Cardiovascular Diseases
NCT01154933

Completed

Exeantide in Type 2 Diabetes on Insulin

Conditions: Type 2 Diabetes
NCT04909333

Recruiting

Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia

Conditions: Endogenous Hyperinsulinism
NCT02981069

Active, not recruiting

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Conditions: Diabetes Mellitus, Type 2
NCT03456687

Completed

Effects of Exenatide on Motor Function and the Brain

Conditions: Parkinson's Disease
NCT04305002

Active, not recruiting

Exenatide Treatment in Parkinson's Disease

Conditions: Parkinson Disease
NCT05482789

Not yet recruiting

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Conditions: Gestational Diabetes
NCT05356104

Recruiting

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

Conditions: Cerebral Small Vessel Disease
NCT04941521

Completed

Exenatide for Treating Cocaine Use Disorder

Conditions: Cocaine Use Disorder
NCT00775684

Completed

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

Conditions: Pre-diabetes, Type 2 Diabetes
NCT04232969

Active, not recruiting

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

Conditions: Parkinson's Disease
NCT02794402

Completed

Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI

Conditions: Obesity
NCT02664441

Completed

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

Conditions: Hypothalamic Obesity
NCT03331289

Active, not recruiting

Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Conditions: Diabetes Mellitus, Type 2
NCT03007329

Completed

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.

Conditions: Steatosis, Liver, Type2 Diabetes
NCT04969627

Completed

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

Conditions: Polycystic Ovary Syndrome
NCT02194595

Completed

Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

Conditions: Type 2 Diabetes
NCT01302327

Withdrawn

GLP Analogs for Diabetes in Wolfram Syndrome Patients

Conditions: Diabetes Mellitus Associated With Genetic Syndrome, Wolfram Syndrome
NCT02787551

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

Conditions: Type 2 Diabetes Mellitus